AHSZX Performance — Alger Health Sciences Fund, Class Z
Data updated: 2026-09-25
AHSZX returned +21.90% year to date and +53.74% over one year to Jul 2026. Annualised returns are +11.06% over 3 years and +6.45% over 5 years. The fund beat its Health Care Equity category average: $100 invested three years ago grew to $137, against $137 for the category, and to $154 over one year, against $137. Volatility over the past three years was 14.97% a year. In the 12 months to Jul 2026 the fund lost a net $14.7M, and assets reached $75.36M.
AHSZX Growth of $100
What $100 invested in Alger Health Sciences Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | AHSZX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $154 | $137 |
| 3 years (Aug 2023 – Jul 2026) | $137 | $137 |
| 5 years (Aug 2021 – Jul 2026) | $137 | $121 |
| Since data start (Aug 2019 – Jul 2026) | $137 | $183 |
AHSZX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +21.90% |
| 1 year | +53.74% |
| 3 years (annualised) | +11.06% |
| 5 years (annualised) | +6.45% |
AHSZX Annual Returns
Calendar-year total returns of Alger Health Sciences Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +21.90% |
| 2025 | +10.59% |
| 2024 | +1.62% |
| 2023 | −0.03% |
| 2022 | −0.16% |
| 2021 | +0.04% |
| 2020 | +0.29% |
| 2019 (Aug–Dec) | +0.05% |
AHSZX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0% | +3.3% | −6.7% | +3.3% | +2.5% | +10.4% | +8.2% | — | — | — | — | — |
| 2025 | +2.9% | −6.7% | −5.6% | −1.4% | −1.0% | +3.0% | −3.9% | +6.3% | +4.1% | +5.6% | +9.7% | −1.6% |
| 2024 | +1.8% | +5.6% | +1.8% | −5.6% | +3.4% | +0.1% | −0.4% | +2.2% | −2.1% | −0.4% | +2.6% | −6.6% |
| 2023 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +0.1% |
| 2022 | −0.1% | 0.0% | 0.0% | −0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +0.1% | 0.0% | 0.0% |
| 2021 | 0.0% | 0.0% | 0.0% | +0.1% | 0.0% | +0.1% | 0.0% | 0.0% | 0.0% | 0.0% | −0.1% | 0.0% |
| 2020 | 0.0% | 0.0% | −0.1% | +0.1% | +0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +0.1% | +0.1% |
| 2019 | — | — | — | — | — | — | — | 0.0% | −0.1% | 0.0% | +0.1% | 0.0% |
AHSZX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 14.97%
- 3-year Sharpe ratio: 0.44 (vs 4.5% risk-free rate)
- Best month: +10.38% (Jun 2026)
- Worst month: −6.71% (Mar 2026)
AHSZX Fund Flows
Monthly money in and out of Alger Health Sciences Fund, from SEC Form N-PORT.
- 12-month net flow: −$14.7M
- 12-month gross sales (incl. reinvestments): $6.5M
- Sales ÷ redemptions: 0.31×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.0M | $977K | $3.0M |
| Jun 2026 | $150K | $1.1M | −$974K |
| May 2026 | $201K | $960K | −$759K |
| Apr 2026 | $138K | $1.1M | −$925K |
| Mar 2026 | $125K | $1.5M | −$1.4M |
| Feb 2026 | $223K | $1.0M | −$827K |
| Jan 2026 | $255K | $1.9M | −$1.6M |
| Dec 2025 | $277K | $2.3M | −$2.1M |
| Nov 2025 | $334K | $1.2M | −$911K |
| Oct 2025 | $280K | $5.7M | −$5.4M |
| Sep 2025 | $378K | $1.8M | −$1.4M |
| Aug 2025 | $157K | $1.5M | −$1.4M |
AHSZX Assets Under Management
Net assets of Alger Health Sciences Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $75.36M |
| 2026-04-30 | $60.86M |
| 2026-01-30 | $64.41M |
| 2025-10-31 | $64.00M |
| 2025-07-31 | $62.31M |
| 2025-04-30 | $68.57M |
| 2025-01-31 | $88.15M |
| 2024-10-31 | $97.76M |
| 2024-07-31 | $105.75M |
| 2024-04-30 | $108.79M |
| 2024-01-31 | $112.40M |
| 2023-10-31 | $117.92M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.